Sermorelin

Published · Researched 2026-09-21

Research file — dated 2026-09-20. Research documentation only; not medical advice.

Overview — maker/originator, what it is, current 2026 status

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) comprising its first 29 amino acids — the biologically active portion of the 44-amino-acid endogenous GHRH. Unusually for a peptide in this space, it has a genuine regulatory history: the FDA approved it in 1990 as a diagnostic agent (Geref Diagnostic) and again in 1997 for treatment of idiopathic GH deficiency in children with growth failure (Geref). In 2008 the manufacturer discontinued it for commercial/manufacturing reasons — the FDA later determined (Federal Register, Docket No. FDA-2012-P-1071) it was not withdrawn for safety or effectiveness reasons, which keeps it eligible for compounding under 503A/503B provisions. In 2026 sermorelin exists primarily as a compounded prescription product dispensed by anti-aging/wellness and telehealth clinics, used off-label in adults for sleep, body composition, and recovery.

Sources: https://medium.com/@lunairelabs/sermorelin-the-peptide-that-started-the-modern-ghrh-category-34f165a164de; https://www.excelmale.com/threads/what-is-sermorelin-and-how-do-growth-hormone-peptides-work.34143/ (both accessed 2026-09-20)

Social standing — platform pulse

  • Instagram: In the RIPD.FIT "Peptides for Muscle Gain Comparison Table" (Dec 2025) sermorelin is one of four compared compounds, dosed 100–300 mcg 1–2x/day with 8–12 week cycles (https://www.instagram.com/p/DS73JZnEyNV/). Dr. Adam Nessim, MD (May 2026 reel) calls it "one of the most clinically established peptides on the list," describing it as a GHRH analog of the first 29 amino acids of GHRH (https://www.instagram.com/reel/DYfEP_wFcUC/). A Sept 2026 KPC Wellness "GHRH + GHRP Overall Ranking" infographic ranks sermorelin mid-pack on human evidence, below tesamorelin and ipamorelin. Nick Barrow's Sept 2026 "top 8 peptides" ranking discusses sermorelin's costs and positioning. An Aug 2026 educational reel clarifies that sermorelin does not spike cortisol, attributing that myth to confusion with GHRP-2/GHRP-6/hexarelin.
  • Facebook Groups: In a Dec 2025 GH peptide thread, Jake Manson (prescribed TRT + sermorelin by his doctor) asks for cardio advice; experienced commenters advise pairing sermorelin with a GHRP such as hexarelin for stronger GH secretion and set expectations of 6–8 weeks to steady state (https://www.facebook.com/groups/746408355930335/permalink/1991273278110497/). In a Feb 2026 thread, a prediabetic (A1c 5.9) asks about sermorelin/ipamorelin/hexarelin and glucose — commenters favor ipamorelin and stress metabolic workup first.
  • Threads: Appears in peptide cheat-sheet style posts; no dominant standalone thread.
  • Group consensus: Sermorelin is positioned as the mildest, oldest, most "grandfathered" GH peptide — gentle, good for sleep, a reasonable first option for older adults — but widely seen as weaker and slower than tesamorelin or CJC-1295/ipamorelin. A creator's shorthand: sermorelin is the "Ford Model T" — first on the scene, still effective but slower with delayed results.
  • Viral moments: The Dec 2025 Scientific American article "The murky science behind human growth hormone peptides" (by Lori Youmshajekian) examines sermorelin and tesamorelin as anti-aging elixirs — widely shared and debated, with enthusiasts citing personal weight loss, sleep gains, and lab-verified IGF-1 increases.
  • Main praise: Most clinically established history of any GH peptide; gentle/pulsatile (doesn't raise cortisol); frequently praised for sleep improvement; compoundable via regulated pharmacies.
  • Main complaints: Weak and slow — podcast clinicians call it the weakest of the three GHRH options (sermorelin < CJC-1295 < tesamorelin, the latter "about 40% stronger"); community members report sluggish results alone and recommend stacking with a GHRP; adult use is off-label.
  • Quotes: Creator on sermorelin's legacy: "Ford Model T." Commenter on sleep: praised sermorelin as "the best for that purpose" (sleep).

Social validation — Tier 1

Tier 1 — FB Groups (detailed patient threads), Instagram (physician-educator content: Dr. Nessim, Dr. Allende, RIPD.FIT), Threads (cheat-sheet coverage), plus mainstream press (Scientific American, Sept 2026).

Named sources:

Key specs table

Spec Detail
Class Synthetic GHRH analog — GHRH(1-29)-NH2 (first 29 amino acids of endogenous 44-aa GHRH)
Mechanism Binds pituitary GHRH receptors → pulsatile endogenous GH synthesis/release; preserves physiological feedback (unlike exogenous rhGH)
Half-life Short (minutes; native-like GHRH kinetics) — exact figure UNVERIFIED
Route Subcutaneous injection (compounded); sublingual/ODT offered by some telehealth platforms (ReadyRX) — offerings UNVERIFIED
Community-reported dosing 100–300 mcg, 1–2x/day on empty stomach, nighttime preferred; 8–12 week cycles (RIPD.FIT table)
Molecular weight / CAS MW ~3,358 Da; CAS 86168-78-7 — UNVERIFIED, not confirmed today
Former brand dosing (Geref) Pediatric GHD indication, 1990–2008 — historic label details not collected

Pricing

  • Approved-drug price: Not applicable — Geref discontinued 2008; no current brand product.
  • Compounded/clinic price: Anti-aging and telehealth clinics (e.g., PeRx via 503A pharmacy, ReadyRX) offer compounded sermorelin programs; exact 2026 program prices not collected — UNVERIFIED. (Historic reporting: compounded sermorelin programs priced below the ~$1,000–3,000/mo cited for synthetic HGH — source: ReadyRX newswire, dated reference.)
  • Research-chem price: Gray-market vial prices not collected 2026-09-20 — UNVERIFIED.
  • Marketplace range: No listings observed 2026-09-20.

What's included / what's needed

  • Compounded: pharmacy-prepared vial(s) with prescription, dispensed with syringes and instructions through the clinic/pharmacy.
  • Research-chem listing: lyophilized vial (5 mg common — UNVERIFIED).
  • What's needed alongside (factual, not instructions): bacteriostatic water for reconstitution, insulin syringes (research-chem context).

Support reality

  • Pharma support: None — original manufacturer product discontinued 2008.
  • COA practices (research chem): Vendors typically post third-party COAs; quality unverified here.
  • Clinic support: Compounded sermorelin is dispensed through licensed providers and FDA-registered 503A/503B pharmacies with prescriber oversight and IGF-1 monitoring per clinic protocols.

Regulatory & safety status

Plain statement: Compounded prescription product, not currently FDA-approved. Was FDA-approved 1990 (diagnostic) and 1997 (pediatric GHD) as Geref/Geref Diagnostic; approvals withdrawn 2008 after voluntary manufacturer discontinuation for commercial reasons (not safety/effectiveness, per FDA). Current adult wellness/anti-aging use is off-label. Eligible for 503A/503B compounding. WADA-prohibited at all times (S2.2.4, GHRH analogs). Safety signals: because it acts via GHRH (not ghrelin) receptors, it does not raise ACTH/cortisol (community-educator claim consistent with the GHRH literature); general GH-axis effects include fluid retention, joint discomfort, and possible glucose/insulin-resistance shifts — monitor IGF-1 and metabolic markers per clinician guidance.

Community verdict

Sermorelin is the community's "safe, gentle, grandfathered" GH peptide — valued for its real clinical history and sleep benefits, and favored for older adults — but consistently ranked the weakest of the GHRH options, with most experienced users recommending it be stacked with a GHRP rather than run alone.

Image log

Open questions / UNVERIFIED

  • Current compounded-program pricing (monthly cost at telehealth clinics).
  • Gray-market vial pricing.
  • Molecular weight (~3,358 Da) and CAS (86168-78-7) — plausible, not verified today.
  • Current FDA 503A/503B bulk-substance list status for sermorelin specifically — eligibility inferred from the "not withdrawn for safety/effectiveness" determination; exact current list placement not checked.
  • Claim that sermorelin is "potentially superior to exogenous rhGH for adult-onset GH insufficiency" (2009 Clinical Interventions in Aging review, cited in forum post) — not verified against the primary source.
  • Whether compounded sermorelin quality is consistent across 503A pharmacies — no data collected.

Not medical advice. This file is research documentation only; nothing here is a recommendation to use any compound.

Sermorelin — detail view
detail view Original vendor page URL not recorded in research dossier
Sermorelin — rear view
rear view Original vendor page URL not recorded in research dossier
Sermorelin — side view
side view Original vendor page URL not recorded in research dossier

Sources